EricEngWalkMDFCAP

Summary

• Dr. Eric Walk is Chief Medical Officer at PathAI in Boston, MA. He is head of the Medical group, overseeing Medical Affairs, Regulatory Affairs, and Clinical Affairs.
  
  Eric has over 20 years of experience in precision medicine, oncology drug development and IVD companion diagnostics development. Prior to joining PathAI, he was Chief Medical and Scientific Officer at Roche Tissue Diagnostics/Ventana Medical Systems, where he led Medical & Scientific Affairs, overseeing the development and FDA clearance/approval of over 20 510k and PMA IVD assays, companion diagnostics and digital pathology algorithms. Eric began his industry career at Novartis Oncology, where he held positions in Early Clinical Development and Translational Medicine, working to implement biomarker and precision medicine strategies for early and late stage targeted oncology therapeutics.
  
  Eric is a Phi Beta Kappa graduate of Johns Hopkins University and holds a MD degree from the University of Virginia School of Medicine. He is board certified in Anatomic and Clinical Pathology and is a Fellow of the College of American Pathologists (CAP). He currently is a member of the CAP Personalized Healthcare Committee.
  
  Recent Publications
  Walk E, Yohe S, Schade A, et al. The Cancer Immunotherapy Biomarker Testing Landscape. Arch Pathol Lab Med. 2020 Jun;144(6):706-724.
  
  Compton C, Robb J, Anderson M,…Walk E et al. Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine. Arch Pathol Lab Med. 2019;1346-1363.